Two-Fraction HDR Monotherapy for Localized Prostate Cancer
17
about 4.5 years
18+
Male only
1 site in CA
Why this study is shown
What this study is about
This trial is testing a treatment called high dose rate (HDR) brachytherapy delivered in two fractions, given 3 hours apart. This treatment aims to see if it's safe and effective as a single treatment option for localized prostate cancer.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Receive High Dose Rate Monotherapy
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: Proportion of participants with treatment-related adverse events
Secondary: Mean Change in International Prostate Symptom Score (IPSS) over time